These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 33349731)

  • 1. [Personalized treatment of depression phenotypes: role of trazodone in depression with insomnia].
    Antonelli Incalzi R; Caraci F; Cuomo A; Fagiolini A; Ferini Strambi L
    Riv Psichiatr; 2020; 55(6):371-379. PubMed ID: 33349731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Trazodone Contramid® in clinical practice: personalizing antidepressant intervention].
    Fagiolini A; Amodeo G; Goracci A; Blardi P
    Riv Psichiatr; 2016; 51(4):123-128. PubMed ID: 27727261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical guidance for the use of trazodone in major depressive disorder and concomitant conditions: pharmacology and clinical practice.
    Cuomo A; Ballerini A; Bruni AC; Decina P; Di Sciascio G; Fiorentini A; Scaglione F; Vampini C; Fagiolini A
    Riv Psichiatr; 2019; 54(4):137-149. PubMed ID: 31379379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Personalized medicine with extended-release trazodone and/or once-a-day trazodone: from research trials to clinical practice].
    Cuomo A; Fiorentini A; Vampini C; Fagiolini A
    Riv Psichiatr; 2020; 55(5):255-261. PubMed ID: 33078017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The efficacy and tolerability of once-daily controlled-release trazodone for depressed mood, anxiety, insomnia, and suicidality in major depressive disorder.
    Sheehan DV; Rozova A; Gossen ER; Gibertini M
    Psychopharmacol Bull; 2009; 42(4):5-22. PubMed ID: 20581790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Confirmation of the neurophysiologically predicted therapeutic effects of trazodone on its target symptoms depression, anxiety and insomnia by postmarketing clinical studies with a controlled-release formulation in depressed outpatients.
    Saletu-Zyhlarz GM; Anderer P; Arnold O; Saletu B
    Neuropsychobiology; 2003; 48(4):194-208. PubMed ID: 14673218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Serotonin neurotrasmission and treatment options for depression].
    Sivolap YP
    Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(11):174-177. PubMed ID: 29265105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rethinking the role of trazodone in the different depressive dimensions.
    Berardelli I; Amerio A; Bartoli F; Cuomo A; Deste G; Orsolini L; Sampogna G; Pompili M
    Expert Rev Neurother; 2024 Jul; 24(7):619-632. PubMed ID: 38881379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rediscovering trazodone for the treatment of major depressive disorder.
    Fagiolini A; Comandini A; Catena Dell'Osso M; Kasper S
    CNS Drugs; 2012 Dec; 26(12):1033-49. PubMed ID: 23192413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Current treatment of depression and agitation in the elderly -- clinical use of trazodone].
    Osváth P
    Neuropsychopharmacol Hung; 2013 Sep; 15(3):147-55. PubMed ID: 24108179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insomnia treatment in the third trimester of pregnancy reduces postpartum depression symptoms: a randomized clinical trial.
    Khazaie H; Ghadami MR; Knight DC; Emamian F; Tahmasian M
    Psychiatry Res; 2013 Dec; 210(3):901-5. PubMed ID: 23993464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative effectiveness of second-generation antidepressants for accompanying anxiety, insomnia, and pain in depressed patients: a systematic review.
    Thaler KJ; Morgan LC; Van Noord M; Gaynes BN; Hansen RA; Lux LJ; Krebs EE; Lohr KN; Gartlehner G
    Depress Anxiety; 2012 Jun; 29(6):495-505. PubMed ID: 22553134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trazodone is only slightly faster than fluoxetine in relieving insomnia in adolescents with depressive disorders.
    Kallepalli BR; Bhatara VS; Fogas BS; Tervo RC; Misra LK
    J Child Adolesc Psychopharmacol; 1997; 7(2):97-107. PubMed ID: 9334895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Efficacy of trazodone in the treatment of insomnia].
    Gałecki P; Florkowski A; Talarowska M
    Pol Merkur Lekarski; 2010 Jun; 28(168):509-12. PubMed ID: 20642116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of prolonged-release trazodone in major depressive disorder: a multicenter, randomized, double-blind, flexible-dose trial.
    Zhang L; Xie WW; Li LH; Zhang HG; Wang G; Chen DC; Cao Y; Cui LJ; Zhang KR; Shi JG; Tan QR; Zheng HB; Xu XF; Cheng ZH; Zhao JP
    Pharmacology; 2014; 94(5-6):199-206. PubMed ID: 25376160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A review of the evidence for the efficacy and safety of trazodone in insomnia.
    Mendelson WB
    J Clin Psychiatry; 2005 Apr; 66(4):469-76. PubMed ID: 15816789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved insomnia symptoms and sleep-related next-day functioning in patients with comorbid major depressive disorder and insomnia following concomitant zolpidem extended-release 12.5 mg and escitalopram treatment: a randomized controlled trial.
    Fava M; Asnis GM; Shrivastava RK; Lydiard B; Bastani B; Sheehan DV; Roth T
    J Clin Psychiatry; 2011 Jul; 72(7):914-28. PubMed ID: 21208597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparative, randomized, double-blind study of trazodone prolonged-release and sertraline in the treatment of major depressive disorder.
    Munizza C; Olivieri L; Di Loreto G; Dionisio P
    Curr Med Res Opin; 2006 Sep; 22(9):1703-13. PubMed ID: 16968574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does trazodone have a role in palliating symptoms?
    Davis MP
    Support Care Cancer; 2007 Feb; 15(2):221-4. PubMed ID: 17131134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Update on Pharmacological Treatment for Comorbid Major Depressive and Alcohol Use Disorders: The Role of Extended-release Trazodone.
    Di Nicola M; Pepe M; Panaccione I; Moccia L; Janiri L; Sani G
    Curr Neuropharmacol; 2023; 21(11):2195-2205. PubMed ID: 37013426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.